摘要
尽管膀胱镜术和尿脱落细胞学是诊断膀胱癌的金标准 ,但它们或具侵入性 ,或缺乏敏感性和特异性。为膀胱癌的早期诊断、监测复发和判断预后寻找新的生物标志物已成为一个研究热点问题。
出处
《国外医学（临床生物化学与检验学分册）》
2002年第1期34-35,共2页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
参考文献5
-
1Stampfer DS,Carpinito GA,Rodriguez-Vilianueva J,et al.Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder[].Journal d Urologie.1998
-
2Grocela J A,Mc Dougal,W S.Utility of nuclear matrix protein(nmp22) in the detecting bladder cancer[].Urologic Clinics of North America.2000
-
3Lokeshwar VB,Block NL.HA-HAase urine test: A sensitive and specific method for detecting bladder cancer and evaluating its grade[].Urologic Clinics of North America.2000
-
4Malkowicz SB.The application of human complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer[].Urologic Clinics of North America.2000
-
5Burchardt M,Burchardt T,Shabsigh A,et al.Current concepts in biomarker technology for bladder cancers[].Clinical Chemistry.2000
同被引文献20
-
1BHUIYAN J, AKHTER J, O'KANE D J. Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder [ J ] .Clin Chim Acta, 2003, 33( 2 ): 69-77.
-
2EISSA S, SWELLAM M, SADEK M, et al. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors [ J ]. J Urol, 2002, 168( 2 ): 465-469.
-
3POULAKIS V, WITZSCH U, DE VRIES R, et al. A comparison of urinary nuclear matrix protein-22 and bladder tumor antigen tests with voided urinary cytology in detecting and following bladder cancer; the prognostic value of false-positive results [ J ]. BJU Int, 2001, 88( 7 ): 692-701.
-
4IARC. Benzidine[ M ]//IARC. Monographs( Suppl 7 ). Lyon: IARC, 1987: 123.
-
5LEE K H. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer [ J ] .Yonsei Med J, 2001,42( 1 ): 14-18.
-
6ZIPPE C, PANDRANGI L, AHARWAL A. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer [ J ]. J Urol, 1999, 161( 1 ): 62-65.
-
7PAPANICOLAOU G N, MARSHAL V F. Urine sediment smears : a diagnostic procedure in cancer of the urinary tract. [ J ]. Science,1945, 101: 519-520.
-
8陈纪刚.上海市联苯胺接触人群职业性膀胱癌的医学监护[J].中国肿瘤,2001,10(4):206-208. 被引量：4
-
9王勤章,周四维,叶章群,蔡丹,向松涛,管维.膀胱癌患者尿液中核有丝分裂器蛋白测定的临床意义[J].实用癌症杂志,2001,16(4):387-389. 被引量：1
-
10金晓明,李双官.膀胱癌患者尿核基质蛋白22检测的临床评价[J].国外医学（临床生物化学与检验学分册）,2001,22(5):237-238. 被引量：1
引证文献2
-
1梁建清.膀胱癌诊断新进展[J].中国综合临床,2005,21(4):379-381. 被引量：4
-
2沈春琳,项翠琴,张胜年,张云英,秦逸秋,袁东,刘茶珍,陈纪刚.核有丝分裂器蛋白22在联苯胺接触人群医学监护中的应用[J].环境与职业医学,2007,24(5):502-503.
二级引证文献4
-
1薄五海.膀胱癌细胞中血管内皮生长因子表达分析[J].中国药物与临床,2006,6(8):613-614. 被引量：1
-
2张伟,李国灏,陈琳,李运柱,陈先国,刘继红,叶章群.EphA2在膀胱移行细胞癌中的表达及其意义[J].现代泌尿外科杂志,2009,14(2):106-109.
-
3杨宏,雷永虹,秦扬,他同生,杨承纲.VEGF和Ki-67在膀胱移行细胞癌中的表达和临床意义[J].河北医药,2011,33(15):2245-2246.
-
4乔菲.术前造口定位对膀胱癌尿流改道腹壁造口患者生活质量的影响[J].中国煤炭工业医学杂志,2013,16(12):2009-2010. 被引量：4
